Sermorelin dosage
Also known as: Geref
What is Sermorelin?
Sermorelin is a synthetic copy of the first 29 amino acids of growth hormone-releasing hormone (GHRH), the shortest fragment that keeps the hormone's full activity. It was sold in the United States as Geref by EMD Serono, approved in 1990 as a test of pituitary function and in 1997 for children with growth failure due to growth hormone deficiency of unknown cause. The brand was discontinued in 2008.
How it works
Sermorelin acts on the pituitary gland the way natural GHRH does, prompting it to release the body's own growth hormone. It is cleared from the blood within minutes, so it produces a brief pulse and does not replace growth hormone directly.
What the evidence shows
The strongest evidence is in children with growth hormone deficiency: a 1999 review found that daily injections increased growth rate in some prepubertal children for at least 12 months, although the gains were smaller than those seen with growth hormone itself and the effect on final adult height was unknown. In adults, evidence is thin. A 1992 study in 10 healthy older men found that two weeks of injections raised growth hormone and IGF-1 levels, but it did not measure body composition or any clinical outcome. Recent reviews describe the evidence for body-composition benefits in healthy adults as limited and indirect, with no long-term data.
Reported side effects
- Pain, redness or swelling at the injection site
- Brief facial flushing
- Headache, nausea and dizziness
- Rare allergic reactions
- Effects of excess growth hormone described by USADA: swelling and fluid build-up, joint and nerve pain, and reduced insulin sensitivity
Cautions
- The FDA-approved brand, Geref, was discontinued in 2008; USADA notes sermorelin now appears to be sold through compounding pharmacies with a prescription and through unregulated online sellers.
- Long-term safety in adults has not been studied.
- USADA warns that black-market or unregulated products may be contaminated or mislabeled.
- Competitive athletes: sermorelin is prohibited in sport, and USADA says a therapeutic use exemption is highly unlikely to be granted.
Legal and regulatory status
Sermorelin was FDA-approved as Geref, but the maker discontinued it in 2008 and the approvals were withdrawn in 2009; in 2013 the FDA determined it had not been withdrawn for safety or effectiveness reasons, and an FDA review describes the withdrawal as a business decision. An FDA list updated in March 2025 places sermorelin acetate among bulk substances under evaluation for compounding by outsourcing facilities (category 1). GHRH and its synthetic analogs, including sermorelin, are prohibited by WADA.
Common questions
Is sermorelin FDA approved?
It was. Geref was approved in 1990 and 1997, then discontinued by its maker in 2008, with approvals withdrawn in 2009. The FDA later determined this was not for safety or effectiveness reasons.
Why was Geref (sermorelin) discontinued?
An FDA review describes it as a business decision by EMD Serono, noting the active ingredient was no longer being manufactured. In 2013 the FDA formally determined that Geref was not withdrawn for reasons of safety or effectiveness.
Does sermorelin work for anti-aging or muscle gain in adults?
That has not been established. A small short study in older men showed higher growth hormone and IGF-1 levels but did not measure muscle, fat or health outcomes, and recent reviews describe the evidence for body-composition benefits as limited and indirect.
Sources
- BioDrugs (1999), PubMed record 18031173: Sermorelin in children with idiopathic growth hormone deficiency
- Federal Register (2013), 78 FR 14096: Determination that Geref was not withdrawn for reasons of safety or effectiveness
- FDA Center for Drug Evaluation and Research: Clinical review, NDA 205598 (Macrilen)
- Journal of Clinical Endocrinology and Metabolism (1992), PubMed record 1379256: GHRH-(1-29) twice daily in old men
- Frontiers in Endocrinology (2026): Performance-enhancing peptides modulating the GH-IGF1 axis
- Translational Andrology and Urology (2020), PubMed record 32257855: Growth hormone secretagogues and body composition
- USADA: What should athletes know about sermorelin?
- FDA: Bulk drug substances nominated for use in compounding under section 503B (updated March 21, 2025)
- Drug Testing and Analysis (2021), PubMed record 34665524: Detection of GHRH synthetic analogs
Sermorelin reviews and Q&A
No reviews or questions yet. Be the first.
Get the printable dosing chart
All 50 peptides on a few pages, as a PDF. We’ll also email you when a peptide’s approval status or dosing changes.
More in Growth hormone
Compare Sermorelin
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.